205 related articles for article (PubMed ID: 33382359)
1. The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation.
Grander C; Grabherr F; Spadoni I; Enrich B; Oberhuber G; Rescigno M; Tilg H
Gut Microbes; 2020 Nov; 12(1):1851986. PubMed ID: 33382359
[TBL] [Abstract][Full Text] [Related]
2. Recovery of ethanol-induced
Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
[TBL] [Abstract][Full Text] [Related]
3. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
4. Conventional type 1 dendritic cells protect against gut barrier disruption via maintaining Akkermansia muciniphila in alcoholic steatohepatitis.
Hao L; Zhong W; Woo J; Wei X; Ma H; Dong H; Guo W; Sun X; Yue R; Zhao J; Zhang Q; Zhou Z
Hepatology; 2023 Sep; 78(3):896-910. PubMed ID: 36626632
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
6. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
7. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
[TBL] [Abstract][Full Text] [Related]
8. Circadian rhythms, alcohol and gut interactions.
Forsyth CB; Voigt RM; Burgess HJ; Swanson GR; Keshavarzian A
Alcohol; 2015 Jun; 49(4):389-98. PubMed ID: 25499101
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli NF73-1 disrupts the gut-vascular barrier and aggravates high-fat diet-induced fatty liver disease via inhibiting Wnt/β-catenin signalling pathway.
Ke Z; Huang Y; Xu J; Liu Y; Zhang Y; Wang Y; Zhang Y; Liu Y
Liver Int; 2024 Mar; 44(3):776-790. PubMed ID: 38225740
[TBL] [Abstract][Full Text] [Related]
10. Solid-state fermented Chinese alcoholic beverage (baijiu) and ethanol resulted in distinct metabolic and microbiome responses.
Fang C; Du H; Zheng X; Zhao A; Jia W; Xu Y
FASEB J; 2019 Jun; 33(6):7274-7288. PubMed ID: 30857422
[TBL] [Abstract][Full Text] [Related]
11. New strain of
Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Osteopontin Protects From Alcohol-induced Liver Injury by Preserving the Gut Microbiome and the Intestinal Barrier Function.
Das S; Song Z; Han H; Ge X; Desert R; Athavale D; Babu Komakula SS; Magdaleno F; Chen W; Lantvit D; Guzman G; Nieto N
Cell Mol Gastroenterol Hepatol; 2022; 14(4):813-839. PubMed ID: 35811073
[TBL] [Abstract][Full Text] [Related]
13. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
Cheng C; Tan J; Qian W; Zhang L; Hou X
Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
[TBL] [Abstract][Full Text] [Related]
14. A critical review on the relationship of herbal medicine, Akkermansia muciniphila, and human health.
Bu F; Zhang S; Duan Z; Ding Y; Chen T; Wang R; Feng Z; Shi G; Zhou J; Chen Y
Biomed Pharmacother; 2020 Aug; 128():110352. PubMed ID: 32521456
[TBL] [Abstract][Full Text] [Related]
15.
Fang C; Cheng J; Jia W; Xu Y
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887381
[TBL] [Abstract][Full Text] [Related]
16. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
[TBL] [Abstract][Full Text] [Related]
17. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
18. Lychee (Litchi chinensis Sonn.) Pulp Phenolic Extract Provides Protection against Alcoholic Liver Injury in Mice by Alleviating Intestinal Microbiota Dysbiosis, Intestinal Barrier Dysfunction, and Liver Inflammation.
Xiao J; Zhang R; Zhou Q; Liu L; Huang F; Deng Y; Ma Y; Wei Z; Tang X; Zhang M
J Agric Food Chem; 2017 Nov; 65(44):9675-9684. PubMed ID: 29041775
[TBL] [Abstract][Full Text] [Related]
19. Gut-liver axis in alcoholic liver disease.
Szabo G
Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
[TBL] [Abstract][Full Text] [Related]
20. Probiotics in the treatment of the liver diseases.
Kirpich IA; McClain CJ
J Am Coll Nutr; 2012 Feb; 31(1):14-23. PubMed ID: 22661622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
